First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours.
Br J Cancer
; 106(8): 1379-85, 2012 Apr 10.
Article
en En
| MEDLINE
| ID: mdl-22491421
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Tetrahidroisoquinolinas
/
Neoplasias
/
Antineoplásicos
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2012
Tipo del documento:
Article